NDSI
Newman Dignan & Sheerar Inc’s Eli Lilly LLY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $800K | Sell |
1,026
-179
| -15% | -$140K | 0.18% | 94 |
|
|
2025
Q1 | $995K | Sell |
1,205
-114
| -9% | -$94.2K | 0.27% | 77 |
|
|
2024
Q4 | $1.02M | Sell |
1,319
-8
| -0.6% | -$6.18K | 0.26% | 77 |
|
|
2024
Q3 | $1.19M | Sell |
1,327
-32
| -2% | -$28.7K | 0.28% | 74 |
|
|
2024
Q2 | $1.23M | Sell |
1,359
-36
| -3% | -$32.6K | 0.32% | 75 |
|
|
2024
Q1 | $1.09M | Sell |
1,395
-85
| -6% | -$66.1K | 0.29% | 83 |
|
|
2023
Q4 | $863K | Buy |
1,480
+100
| +7% | +$58.3K | 0.26% | 89 |
|
|
2023
Q3 | $741K | Hold |
1,380
| – | – | 0.24% | 91 |
|
|
2023
Q2 | $647K | Hold |
1,380
| – | – | 0.2% | 104 |
|
|
2023
Q1 | $474K | Sell |
1,380
-6
| -0.4% | -$2.06K | 0.15% | 115 |
|
|
2022
Q4 | $507K | Sell |
1,386
-49
| -3% | -$17.9K | 0.17% | 110 |
|
|
2022
Q3 | $464 | Buy |
1,435
+5
| +0.3% | +$2 | 0.07% | 113 |
|
|
2022
Q2 | $464K | Hold |
1,430
| – | – | 0.16% | 119 |
|
|
2022
Q1 | $410 | Hold |
1,430
| – | – | 0.08% | 122 |
|
|
2021
Q4 | $395K | Hold |
1,430
| – | – | 0.12% | 127 |
|
|
2021
Q3 | $330K | Buy |
1,430
+200
| +16% | +$46.2K | 0.1% | 140 |
|
|
2021
Q2 | $282K | Sell |
1,230
-392
| -24% | -$89.9K | 0.1% | 153 |
|
|
2021
Q1 | $303K | Hold |
1,622
| – | – | 0.11% | 140 |
|
|
2020
Q4 | $274 | Hold |
1,622
| – | – | 0.04% | 142 |
|
|
2020
Q3 | $240K | Buy |
+1,622
| New | +$240K | 0.1% | 144 |
|
|
2020
Q2 | – | Sell |
-1,380
| Closed | -$209K | – | 148 |
|
|
2020
Q1 | $209K | Buy |
+1,380
| New | +$209K | 0.11% | 133 |
|